Brief: Precision Biosciences Receives U.S. Patent Allowance Covering Pbgene-Pmm For M.3243-Associated Mitochondrial Diseases
27/09/2023 12:05
Sept 27 (Reuters) - Precision BioSciences Inc DTIL.O :
* PRECISION BIOSCIENCES RECEIVES U.S. PATENT ALLOWANCE
COVERING
PBGENE-PMM FOR M.3243-ASSOCIATED MITOCHONDRIAL DISEASES
* PRECISION BIOSCIENCES INC - ONCE ISSUED, PATENT ARISING
FROM
THIS APPLICATION WILL HAVE A STANDARD EXPIRATION DATE IN APRIL
2042
Source text for Eikon: ID:nBwbSrrHwa
Further company coverage: DTIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precision Biosciences
See all newsPrecision BioSciences Inc reports results for the quarter ended June 30 - Earnings Summary
Precision BioSciences Q2 net loss widens on warrant liability charge
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Precision Biosciences - Enters First Amendment To Loan And Security Agreement With Banc Of California - SEC Filing